Merck Singapore R&D Collab Looks To Get Peptides Into Cells
Merck & Co is tapping government scientific researchers in Singapore to help overcome some of the limitations of macrocyclic peptide therapeutics.
You may also be interested in...
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.